
Patrick J. Nolan
Examiner (ID: 12181)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1816, 1621, 1644 |
| Total Applications | 523 |
| Issued Applications | 285 |
| Pending Applications | 114 |
| Abandoned Applications | 124 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3774870
[patent_doc_number] => 05756699
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Immunotoxins comprising ribosome-inactivating proteins'
[patent_app_type] => 1
[patent_app_number] => 8/477484
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 47535
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756699.pdf
[firstpage_image] =>[orig_patent_app_number] => 477484
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477484 | Immunotoxins comprising ribosome-inactivating proteins | Jun 6, 1995 | Issued |
Array
(
[id] => 3935266
[patent_doc_number] => 05989550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Materials and methods for immunocontraception'
[patent_app_type] => 1
[patent_app_number] => 8/480150
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 49985
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/989/05989550.pdf
[firstpage_image] =>[orig_patent_app_number] => 480150
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480150 | Materials and methods for immunocontraception | Jun 6, 1995 | Issued |
Array
(
[id] => 3935654
[patent_doc_number] => 05981228
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Mammalian ZPAs'
[patent_app_type] => 1
[patent_app_number] => 8/484596
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 51807
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981228.pdf
[firstpage_image] =>[orig_patent_app_number] => 484596
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484596 | Mammalian ZPAs | Jun 6, 1995 | Issued |
Array
(
[id] => 3841614
[patent_doc_number] => 05744580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Immunotoxins comprising ribosome-inactivating proteins'
[patent_app_type] => 1
[patent_app_number] => 8/488113
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46648
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744580.pdf
[firstpage_image] =>[orig_patent_app_number] => 488113
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488113 | Immunotoxins comprising ribosome-inactivating proteins | Jun 6, 1995 | Issued |
| 08/485610 | COMPOSITIONS AND METHODS OF USING TERMINALLY LABELED PEPTIDES THAT BIND MHC CLASS I MOLECULES | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4234667
[patent_doc_number] => 06080407
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Diagnostic assays for MIF'
[patent_app_type] => 1
[patent_app_number] => 8/471586
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 32868
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080407.pdf
[firstpage_image] =>[orig_patent_app_number] => 471586
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471586 | Diagnostic assays for MIF | Jun 5, 1995 | Issued |
Array
(
[id] => 3659521
[patent_doc_number] => 05648242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Method of production of birch pollen allergen P14'
[patent_app_type] => 1
[patent_app_number] => 8/469555
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 7781
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648242.pdf
[firstpage_image] =>[orig_patent_app_number] => 469555
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469555 | Method of production of birch pollen allergen P14 | Jun 5, 1995 | Issued |
| 08/468902 | DRUG BINDING PROTEIN | Jun 5, 1995 | Abandoned |
Array
(
[id] => 3781615
[patent_doc_number] => 05736149
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Allergenic proteins and peptides from johnson grass pollen'
[patent_app_type] => 1
[patent_app_number] => 8/470165
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 16770
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736149.pdf
[firstpage_image] =>[orig_patent_app_number] => 470165
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470165 | Allergenic proteins and peptides from johnson grass pollen | Jun 5, 1995 | Issued |
Array
(
[id] => 3630774
[patent_doc_number] => 05686580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Antibodies having binding specificity to ShET2, an enterotoxin of Shigella flexneri 2A'
[patent_app_type] => 1
[patent_app_number] => 8/471154
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 12657
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686580.pdf
[firstpage_image] =>[orig_patent_app_number] => 471154
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471154 | Antibodies having binding specificity to ShET2, an enterotoxin of Shigella flexneri 2A | Jun 5, 1995 | Issued |
Array
(
[id] => 4385132
[patent_doc_number] => 06277962
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Receptor on the surface of activated t-cells: act-4'
[patent_app_type] => 1
[patent_app_number] => 8/472940
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 16700
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277962.pdf
[firstpage_image] =>[orig_patent_app_number] => 472940
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472940 | Receptor on the surface of activated t-cells: act-4 | Jun 5, 1995 | Issued |
Array
(
[id] => 3880564
[patent_doc_number] => 05798216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Antibodies and immunoassays for detecting platelet transfusion refractoriness'
[patent_app_type] => 1
[patent_app_number] => 8/470137
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9607
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798216.pdf
[firstpage_image] =>[orig_patent_app_number] => 470137
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470137 | Antibodies and immunoassays for detecting platelet transfusion refractoriness | Jun 5, 1995 | Issued |
| 08/462350 | INHIBITION OF MIGRATION INHIBITORY FACTOR IN THE TREATMENT OF DISEASES INVOLVING CYTOKINE-MEDIATED TOXICITY | Jun 4, 1995 | Abandoned |
Array
(
[id] => 4034489
[patent_doc_number] => 05994514
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Immunoglobulin variants'
[patent_app_type] => 1
[patent_app_number] => 8/464025
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14294
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994514.pdf
[firstpage_image] =>[orig_patent_app_number] => 464025
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464025 | Immunoglobulin variants | Jun 4, 1995 | Issued |
Array
(
[id] => 3837421
[patent_doc_number] => 05707632
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Receptors for fibroblast growth factors'
[patent_app_type] => 1
[patent_app_number] => 8/458938
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 20033
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/707/05707632.pdf
[firstpage_image] =>[orig_patent_app_number] => 458938
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458938 | Receptors for fibroblast growth factors | Jun 1, 1995 | Issued |
Array
(
[id] => 3909304
[patent_doc_number] => 06001599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'DNAs encoding mammalian ZPBs'
[patent_app_type] => 1
[patent_app_number] => 8/458731
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 51806
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001599.pdf
[firstpage_image] =>[orig_patent_app_number] => 458731
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458731 | DNAs encoding mammalian ZPBs | Jun 1, 1995 | Issued |
Array
(
[id] => 3919815
[patent_doc_number] => 05945096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Method for recombinant production of biologically active polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/456460
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 34647
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945096.pdf
[firstpage_image] =>[orig_patent_app_number] => 456460
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456460 | Method for recombinant production of biologically active polypeptides | May 31, 1995 | Issued |
Array
(
[id] => 3988939
[patent_doc_number] => 05919449
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Porcine cardiomyocytes and their use in treatment of insufficient cardiac function'
[patent_app_type] => 1
[patent_app_number] => 8/454989
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13982
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919449.pdf
[firstpage_image] =>[orig_patent_app_number] => 454989
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454989 | Porcine cardiomyocytes and their use in treatment of insufficient cardiac function | May 29, 1995 | Issued |
Array
(
[id] => 4413891
[patent_doc_number] => 06193979
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands'
[patent_app_type] => 1
[patent_app_number] => 8/450274
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31511
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/193/06193979.pdf
[firstpage_image] =>[orig_patent_app_number] => 450274
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450274 | Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands | May 24, 1995 | Issued |
Array
(
[id] => 1009123
[patent_doc_number] => 06899883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 08/737446
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 2881
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/899/06899883.pdf
[firstpage_image] =>[orig_patent_app_number] => 08737446
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/737446 | Treatment of diabetes | May 11, 1995 | Issued |